C2orf48
Putative uncharacterized protein C2orf48
Also known as: CB048_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for C2orf48 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
159 residues, UniProt reviewed canonical sequence.
>Q96LS8|C2orf48
1 MESRPSGRQH ASEGDGDQSP TQCAGMRSSG RSDQPYVLKG NPLLLRVRCY SGCASGSGRQ
61 LQLSVFQDLN QFSHCRVWRS PALIVKGEPP WCSQQDTQSP FQTGTPLERP CFRMKLSGWE
121 LTKNAQRALG SKLQHILSLD STQACGAGGP TILRPPRAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C2orf48 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0.3
- gnomAD missense Z
- 0.35
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C2orf48 as an antibody target. Whether an autoantibody or antibody against C2orf48 could matter depends on whether native C2orf48 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C2orf48 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label C2orf48 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...